QuantRx Biomedical Corporation (QTXB)
USD 0.0
(400.0%)
USD 0.0
(400.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | - USD | -100.0% |
| 2021 | 2.64 Million USD | 8.64% |
| 2020 | 2.43 Million USD | 7.54% |
| 2019 | 2.26 Million USD | 8.5% |
| 2018 | 2.08 Million USD | -2.44% |
| 2017 | 2.14 Million USD | 13.18% |
| 2016 | 1.89 Million USD | 5.61% |
| 2015 | 1.79 Million USD | 5.0% |
| 2014 | 1.7 Million USD | 56.78% |
| 2013 | 1.08 Million USD | 27.44% |
| 2012 | 853.56 Thousand USD | 89.2% |
| 2011 | 451.14 Thousand USD | -46.65% |
| 2010 | 845.57 Thousand USD | -38.07% |
| 2009 | 1.36 Million USD | -79.11% |
| 2008 | 6.53 Million USD | 260.76% |
| 2007 | 1.81 Million USD | 142.72% |
| 2006 | 746.45 Thousand USD | 179.35% |
| 2005 | 267.21 Thousand USD | -62.98% |
| 2004 | 721.86 Thousand USD | -35.68% |
| 2003 | 1.12 Million USD | 2.75% |
| 2002 | 1.09 Million USD | -13.99% |
| 2001 | 1.27 Million USD | 62.82% |
| 2000 | 780 Thousand USD | 8.33% |
| 1999 | 720 Thousand USD | -37.39% |
| 1998 | 1.15 Million USD | -7.26% |
| 1997 | 1.24 Million USD | 2.48% |
| 1996 | 1.21 Million USD | 332.14% |
| 1995 | 280 Thousand USD | -87.44% |
| 1994 | 2.23 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q1 | 2.7 Million USD | 2.17% |
| 2022 Q2 | 2.78 Million USD | 2.94% |
| 2022 FY | - USD | -100.0% |
| 2022 Q4 | - USD | -100.0% |
| 2022 Q3 | 2.84 Million USD | 2.22% |
| 2021 Q1 | 2.48 Million USD | 2.14% |
| 2021 FY | 2.64 Million USD | 8.64% |
| 2021 Q4 | 2.64 Million USD | 1.77% |
| 2021 Q3 | 2.6 Million USD | 2.21% |
| 2021 Q2 | 2.54 Million USD | 2.26% |
| 2020 Q4 | 2.43 Million USD | 2.43% |
| 2020 FY | 2.43 Million USD | 7.54% |
| 2020 Q1 | 2.28 Million USD | 0.85% |
| 2020 Q2 | 2.33 Million USD | 2.22% |
| 2020 Q3 | 2.37 Million USD | 1.84% |
| 2019 Q4 | 2.26 Million USD | 3.0% |
| 2019 Q1 | 2.15 Million USD | 2.96% |
| 2019 Q2 | 2.15 Million USD | 0.3% |
| 2019 Q3 | 2.19 Million USD | 2.01% |
| 2019 FY | 2.26 Million USD | 8.5% |
| 2018 FY | 2.08 Million USD | -2.44% |
| 2018 Q1 | 2.17 Million USD | 1.69% |
| 2018 Q4 | 2.08 Million USD | -0.79% |
| 2018 Q3 | 2.1 Million USD | -5.09% |
| 2018 Q2 | 2.21 Million USD | 1.9% |
| 2017 Q3 | 2.11 Million USD | 1.14% |
| 2017 Q1 | 2 Million USD | 6.19% |
| 2017 FY | 2.14 Million USD | 13.18% |
| 2017 Q4 | 2.14 Million USD | 1.38% |
| 2017 Q2 | 2.08 Million USD | 3.95% |
| 2016 FY | 1.89 Million USD | 5.61% |
| 2016 Q3 | 1.8 Million USD | -4.86% |
| 2016 Q2 | 1.89 Million USD | 3.56% |
| 2016 Q4 | 1.89 Million USD | 5.04% |
| 2016 Q1 | 1.82 Million USD | 2.05% |
| 2015 FY | 1.79 Million USD | 5.0% |
| 2015 Q4 | 1.79 Million USD | 0.99% |
| 2015 Q1 | 1.75 Million USD | 2.69% |
| 2015 Q2 | 1.75 Million USD | 0.07% |
| 2015 Q3 | 1.77 Million USD | 1.18% |
| 2014 Q3 | 1.54 Million USD | 17.66% |
| 2014 Q2 | 1.3 Million USD | 0.7% |
| 2014 FY | 1.7 Million USD | 56.78% |
| 2014 Q4 | 1.7 Million USD | 10.69% |
| 2014 Q1 | 1.3 Million USD | 19.55% |
| 2013 FY | 1.08 Million USD | 27.44% |
| 2013 Q1 | 893.92 Thousand USD | 4.73% |
| 2013 Q2 | 918.61 Thousand USD | 2.76% |
| 2013 Q3 | 970.66 Thousand USD | 5.67% |
| 2013 Q4 | 1.08 Million USD | 12.07% |
| 2012 Q1 | 552.08 Thousand USD | 22.37% |
| 2012 Q3 | 786.88 Thousand USD | 17.72% |
| 2012 Q4 | 853.56 Thousand USD | 8.47% |
| 2012 FY | 853.56 Thousand USD | 89.2% |
| 2012 Q2 | 668.43 Thousand USD | 21.07% |
| 2011 FY | 451.14 Thousand USD | -46.65% |
| 2011 Q4 | 451.14 Thousand USD | 5.94% |
| 2011 Q3 | 425.83 Thousand USD | 35.57% |
| 2011 Q2 | 314.11 Thousand USD | -40.93% |
| 2011 Q1 | 531.78 Thousand USD | -37.11% |
| 2010 Q2 | 1.58 Million USD | 15.93% |
| 2010 Q4 | 845.57 Thousand USD | -60.15% |
| 2010 FY | 845.57 Thousand USD | -38.07% |
| 2010 Q3 | 2.12 Million USD | 33.9% |
| 2010 Q1 | 1.36 Million USD | 0.12% |
| 2009 Q3 | 1.62 Million USD | -74.5% |
| 2009 Q1 | 7.65 Million USD | 17.07% |
| 2009 FY | 1.36 Million USD | -79.11% |
| 2009 Q4 | 1.36 Million USD | -16.13% |
| 2009 Q2 | 6.38 Million USD | -16.56% |
| 2008 Q4 | 6.53 Million USD | 16.39% |
| 2008 Q1 | 2.76 Million USD | 52.43% |
| 2008 Q2 | 4.13 Million USD | 49.68% |
| 2008 Q3 | 5.61 Million USD | 35.86% |
| 2008 FY | 6.53 Million USD | 260.76% |
| 2007 Q3 | 980.04 Thousand USD | -10.08% |
| 2007 Q4 | 1.81 Million USD | 84.87% |
| 2007 Q2 | 1.08 Million USD | 43.57% |
| 2007 FY | 1.81 Million USD | 142.72% |
| 2007 Q1 | 759.14 Thousand USD | 1.7% |
| 2006 FY | 746.45 Thousand USD | 179.35% |
| 2006 Q1 | 1.78 Million USD | 568.96% |
| 2006 Q2 | 2.75 Million USD | 54.16% |
| 2006 Q3 | 4.1 Million USD | 49.12% |
| 2006 Q4 | 746.45 Thousand USD | -81.84% |
| 2005 Q4 | 267.21 Thousand USD | -63.56% |
| 2005 Q2 | 665.91 Thousand USD | -7.75% |
| 2005 Q3 | 733.39 Thousand USD | 10.13% |
| 2005 Q1 | 721.86 Thousand USD | 0.0% |
| 2005 FY | 267.21 Thousand USD | -62.98% |
| 2004 FY | 721.86 Thousand USD | -35.68% |
| 2004 Q4 | 721.86 Thousand USD | 0.0% |
| 2003 FY | 1.12 Million USD | 2.75% |
| 2003 Q4 | 1.12 Million USD | 0.0% |
| 2002 Q1 | 1.3 Million USD | 2.36% |
| 2002 Q4 | 1.09 Million USD | 0.0% |
| 2002 FY | 1.09 Million USD | -13.99% |
| 2001 FY | 1.27 Million USD | 62.82% |
| 2001 Q1 | 1.03 Million USD | 32.05% |
| 2001 Q4 | 1.27 Million USD | 2.42% |
| 2001 Q3 | 1.24 Million USD | 8.77% |
| 2001 Q2 | 1.14 Million USD | 10.68% |
| 2000 Q2 | 620 Thousand USD | -15.07% |
| 2000 Q4 | 780 Thousand USD | 23.81% |
| 2000 Q3 | 630 Thousand USD | 1.61% |
| 2000 Q1 | 730 Thousand USD | 1.39% |
| 2000 FY | 780 Thousand USD | 8.33% |
| 1999 Q2 | 850 Thousand USD | -8.6% |
| 1999 Q1 | 930 Thousand USD | -19.13% |
| 1999 Q3 | 830 Thousand USD | -2.35% |
| 1999 Q4 | 720 Thousand USD | -13.25% |
| 1999 FY | 720 Thousand USD | -37.39% |
| 1998 FY | 1.15 Million USD | -7.26% |
| 1998 Q3 | 890 Thousand USD | -27.05% |
| 1998 Q2 | 1.22 Million USD | 29.79% |
| 1998 Q4 | 1.15 Million USD | 29.21% |
| 1998 Q1 | 940 Thousand USD | -24.19% |
| 1997 Q3 | 860 Thousand USD | -24.56% |
| 1997 Q4 | 1.24 Million USD | 44.19% |
| 1997 Q2 | 1.14 Million USD | 3.64% |
| 1997 Q1 | 1.1 Million USD | -9.09% |
| 1997 FY | 1.24 Million USD | 2.48% |
| 1996 Q3 | 470 Thousand USD | -2.08% |
| 1996 Q1 | 680 Thousand USD | 142.86% |
| 1996 FY | 1.21 Million USD | 332.14% |
| 1996 Q2 | 480 Thousand USD | -29.41% |
| 1996 Q4 | 1.21 Million USD | 157.45% |
| 1995 Q4 | 280 Thousand USD | 115.38% |
| 1995 Q1 | 2.16 Million USD | -3.14% |
| 1995 Q2 | 60 Thousand USD | -97.22% |
| 1995 Q3 | 130 Thousand USD | 116.67% |
| 1995 FY | 280 Thousand USD | -87.44% |
| 1994 FY | 2.23 Million USD | 0.0% |
| 1994 Q3 | 320 Thousand USD | 3.23% |
| 1994 Q2 | 310 Thousand USD | 0.0% |
| 1994 Q4 | 2.23 Million USD | 596.88% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | 100.0% |
| Ansell Limited | 1.32 Billion USD | 100.0% |
| Ansell Limited | 1.33 Billion USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 126.33 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | 943.17 Thousand USD | 100.0% |
| Psykey, Inc. | 2.47 Million USD | 100.0% |
| ConvaTec Group Plc | 2.01 Billion USD | 100.0% |
| ConvaTec Group Plc | 2.02 Billion USD | 100.0% |
| Encision Inc. | 1.98 Million USD | 100.0% |
| Golden Valley Development, Inc | - USD | NaN% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | 100.0% |
| Innovative MedTech Inc. | 6.13 Million USD | 100.0% |
| LifePoint, Inc. | 2.45 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | 100.0% |
| Remedent, Inc. | 3.04 Million USD | 100.0% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | 982.26 Million USD | 100.0% |
| Sector 10, Inc. | 9.84 Million USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 100.0% |
| SheerVision, Inc. | 1.43 Million USD | 100.0% |
| United Health Products, Inc. | 1.99 Million USD | 100.0% |
| Vasamed, Inc. | 1 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | 100.0% |
| Yubo International Biotech Limited | 2.91 Million USD | 100.0% |